Works by Nair, Kavita V.

Results: 42

Evaluation of Plasma Neurofilament Light Chain Levels as a Biomarker of Neuronal Injury in the Active and Chronic Phases of Autoimmune Neurologic Disorders.

Published in:

Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.689975

By:

Kammeyer, Ryan;
Mizenko, Christopher;
Sillau, Stefan;
Richie, Alanna;
Owens, Gregory;
Nair, Kavita V.;
Alvarez, Enrique;
Vollmer, Timothy L.;
Bennett, Jeffrey L.;
Piquet, Amanda L.

Publication type:

Article

Real-world cost of care and site of care in patients with multiple sclerosis initiating infused disease-modifying therapies.

Published in:

Journal of Medical Economics, 2023, v. 26, n. 1, p. 494, doi. 10.1080/13696998.2023.2194185

By:

Alvarez, Enrique;
Nair, Kavita V.;
Tan, Hiangkiat;
Rathi, Kapil;
Gabler, Nicole B.;
Maiese, Eric M.;
Deshpande, Chinmay;
Shao, Qiujun

Publication type:

Article

Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE).

Published in:

2019

By:

Carlson, Kevin V.;
Rovner, Eric S.;
Nair, Kavita V.;
Deal, Anna S.;
Kristy, Rita M.;
Schermer, Carol R.

Publication type:

journal article

Plasma biomarkers of neurodegeneration in the brain (UCH‐L1 and NfL) become exponentially higher with age from early childhood, and treatment of Alzheimer's disease participants with granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) lowers age‐associated levels of plasma UCH‐L1 by six decades

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.092726

By:

Sillau, Stefan H;
Coughlan, Christina M;
Ahmed, Md. Mahiuddin;
Nair, Kavita V;
Araya, Paula;
Galbraith, Matthew D.;
Bettcher, Brianne M;
Espinosa, Joaquin M.;
Chial, Heidi J;
Epperson, Neill;
Boyd, Timothy D.;
Potter, Huntington

Publication type:

Article

Developing the 4R model for care delivery, coordination, and patient and their care partners self‐management for suspected or diagnosed Alzheimer's disease and related dementias.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 20, p. 1, doi. 10.1002/alz.074989

By:

Weldon, Christine B;
Zwerling, Jessica;
Martin, Joanna;
Wolf, Michael S;
Rapkin, Bruce;
Nair, Kavita V;
Phillips, Kathryn A;
Epperly, Mikele;
Yagnik, Supriya Kumar;
Trosman, Julia R

Publication type:

Article

Blood-based biomarkers of neuronal and glial injury in active major neuropsychiatric systemic lupus erythematosus.

Published in:

Lupus, 2024, v. 33, n. 10, p. 1116, doi. 10.1177/09612033241272961

By:

Kammeyer, Ryan;
Chapman, Kimberly;
Furniss, Anna;
Hsieh, Elena;
Fuhlbrigge, Robert;
Ogbu, Ekemini A.;
Boackle, Susan;
Zell, JoAnn;
Nair, Kavita V.;
Borko, Tyler L.;
Cooper, Jennifer C.;
Bennett, Jeffrey L.;
Piquet, Amanda L.

Publication type:

Article

Evaluation of P & T Committee performance: An exploratory study.

Published in:

Formulary, 2001, v. 36, n. 2, p. 136

By:

Nair, Kavita V.;
Ascione, Frank J.

Publication type:

Article

The cost of inpatient death associated with acute coronary syndrome.

Published in:

2016

By:

Page II, Robert L.;
Ghushchyan, Vahram;
Van Den Bos, Jill;
Gray, Travis J.;
Hoetzer, Greta L.;
Bhandary, Durgesh;
Nair, Kavita V.;
Page, Robert L 2nd

Publication type:

journal article

Indirect and direct costs of acute coronary syndromes with comorbid atrial fibrillation, heart failure, or both.

Published in:

Vascular Health & Risk Management, 2015, v. 11, p. 25, doi. 10.2147/VHRM.S72331

By:

Ghushchyan, Vahram;
Nair, Kavita V.;
Page II, Robert L.

Publication type:

Article

Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap.

Published in:

Drug, Healthcare & Patient Safety, 2012, v. 4, p. 67, doi. 10.2147/DHPS.S32473

By:

Page II, Robert Lee;
Ghushchyan, Vahram;
Allen, Richard R.;
Roper, Lisa;
Beck, Don;
Jonathan, Bamrom H.;
Frech-Tamas, Feride;
Chan, Wing;
McQueen, R. Brett;
Nair, Kavita V.

Publication type:

Article

Prescription Co-pay Reduction Program for Diabetic Employees.

Published in:

Population Health Management, 2010, v. 13, n. 5, p. 235, doi. 10.1089/pop.2009.0066

By:

Nair, Kavita V.;
Miller, Kerri;
Park, Jinhee;
Allen, Richard R.;
Saseen, Joseph J.;
Biddle, Vinita

Publication type:

Article

Integrating Clinical Pharmacy Services Into Comprehensive Multiple Sclerosis Care Teams: A Narrative Review of 4 Models.

Published in:

International Journal of MS Care, 2025, v. 27, p. 117, doi. 10.7224/1537-2073.2024-019

By:

Bozinov, Nina;
Ramsrud, Autumn;
Montgomery, Jenelle H.;
Merrill, Steven;
Rajkovic, Sarah N.;
Nair, Kavita V.

Publication type:

Article

Comparing clinical effectiveness and drug toxicity with hydrochlorothiazide and chlorthalidone using two potency ratios in a managed care population.

Published in:

2015

By:

Saseen, Joseph J;
Ghushchyan, Vahram;
Nair, Kavita V

Publication type:

journal article

Comparing Clinical Effectiveness and Drug Toxicity With Hydrochlorothiazide and Chlorthalidone Using Two Potency Ratios in a Managed Care Population.

Published in:

Journal of Clinical Hypertension, 2015, v. 17, n. 2, p. 134, doi. 10.1111/jch.12453

By:

Saseen, Joseph J.;
Ghushchyan, Vahram;
Nair, Kavita V.

Publication type:

Article

Comparison of New-Onset Gout in Adults Prescribed Chlorthalidone vs Hydrochlorothiazide for Hypertension.

Published in:

Journal of Clinical Hypertension, 2014, v. 16, n. 12, p. 864, doi. 10.1111/jch.12413

By:

Wilson, Liza;
Nair, Kavita V.;
Saseen, Joseph J.

Publication type:

Article

Maintaining Goal Blood Pressures After Switching From Olmesartan to Other Angiotensin Receptor Blockers.

Published in:

Journal of Clinical Hypertension, 2013, v. 15, n. 12, p. 888, doi. 10.1111/jch.12197

By:

Saseen, Joseph J.;
Ghushchyan, Vahram;
Kaila, Shuchita;
Allen, Richard R.;
Nair, Kavita V.

Publication type:

Article

Tolerability and Safety of Switching from Rituximab to Ocrelizumab: Evaluating Factors Associated with Infusion Related Reactions.

Published in:

Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2022, p. 1, doi. 10.1177/20552173211069359

By:

Alvarez, Enrique;
Nair, Kavita V.;
Sillau, Stefan;
Shelton, Ian;
Seale, Rebecca;
Selva, Sean;
Corboy, John;
Vollmer, Timothy L

Publication type:

Article

Patient-reported outcomes in multiple sclerosis: Validation of the Quality of Life in Neurological Disorders (Neuro-QoL<sup>TM</sup>) short forms.

Published in:

Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2019, v. 5, n. 4, p. 1, doi. 10.1177/2055217319885986

By:

Medina, Luis D.;
Torres, Stephanie;
Alvarez, Enrique;
Valdez, Brooke;
Nair, Kavita V.

Publication type:

Article

One-Year Clinical Effectiveness Comparison of Prasugrel with Ticagrelor: Results from a Retrospective Observational Study using an Integrated Claims Database.

Published in:

American Journal of Cardiovascular Drugs, 2018, v. 18, n. 2, p. 129, doi. 10.1007/s40256-017-0255-y

By:

Effron, Mark B.;
Nair, Kavita V.;
Molife, Cliff;
Keller, Stuart Y.;
Page, Robert L.;
Simeone, Jason C.;
Murphy, Brian;
Nordstrom, Beth L.;
Zhu, Yajun;
McCollam, Patrick L.;
Vetrovec, George W.

Publication type:

Article

Persistence with mirabegron or antimuscarinic treatment for overactive bladder syndrome: Findings from the PERSPECTIVE registry study.

Published in:

LUTS (1757-5664), 2021, v. 13, n. 4, p. 425, doi. 10.1111/luts.12382

By:

Carlson, Kevin V.;
Rovner, Eric S.;
Nair, Kavita V.;
Deal, Anna S.;
Kristy, Rita M.;
Hairston, John C.

Publication type:

Article

Impact of Prescription Benefit Coverage Limits on Sevelamer Hydrochloride Adherence for Patients with ESRD.

Published in:

American Health & Drug Benefits, 2009, v. 2, n. 6, p. 242

By:

Bhardwaja, Bharati;
Carroll, Nikki;
Korner, Eli;
Nair, Kavita V.

Publication type:

Article

Prescription Copay Reduction Program for Diabetic Employees: Impact on Medication Compliance and Healthcare Costs and Utilization.

Published in:

American Health & Drug Benefits, 2009, v. 2, n. 1, p. 14

By:

Nair, Kavita V.;
Miller, Kerry;
Saseen, Joseph;
Wolfe, Pamela;
Allen, Richard Read;
Park, Jinhee

Publication type:

Article

Alternative approaches to measuring value: an update on innovative methods in the context of the United States Medicare drug price negotiation program.

Published in:

2024

By:

DiStefano, Michael J.;
Zemplenyi, Antal;
Anderson, Kelly E.;
Mendola, Nicholas D.;
Nair, Kavita V.;
McQueen, Robert Brett

Publication type:

Report

Incorporating real-world clinical practice in multiple sclerosis economic evaluations.

Published in:

2015

By:

Brett McQueen, R;
Nair, Kavita V;
Vollmer, Timothy L;
Campbell, Jonathan D;
McQueen, R Brett

Publication type:

Editorial

Claims analysis of hypertension occurrence, severity changes and patterns of antihypertensive use in cancer patients receiving vascular endothelial growth factor inhibitors.

Published in:

Journal of Oncology Pharmacy Practice, 2015, v. 21, n. 4, p. 258, doi. 10.1177/1078155214530177

By:

Thompson, Lisa A.;
Saseen, Joseph J.;
O'Bryant, Cindy L.;
Allen, Richard R.;
Nair, Kavita V.

Publication type:

Article

Curing Chronic Hepatitis C: A Cost Comparison of the Combination Simeprevir Plus Sofosbuvir vs. Protease-Inhibitor-Based Triple Therapy.

Published in:

Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2017, v. 16, n. 3, p. 366, doi. 10.5604/01.3001.0009.8591

By:

Langness, Jacob A.;
Tabano, David;
Wieland, Amanda;
Tise, Sarah;
Pratt, Lindsay;
Harrington, Lauren Ayres;
Lin, Sonia;
Ghuschcyan, Vahram;
Nair, Kavita V.;
Everson, Gregory T.

Publication type:

Article

Categorization of infliximab dose changes and healthcare utilization and expenditures for patients with rheumatoid arthritis in commercially insured and Medicare-eligible populations.

Published in:

Current Medical Research & Opinion, 2009, v. 25, n. 2, p. 303, doi. 10.1185/03007990802598736

By:

Kavita V. Nair;
Boxiong Tang;
Jill Van Den Bos;
Vicki Zhang;
Joseph J. Saseen;
Ahmad Naim;
Mirza Rahman

Publication type:

Article

Assessing the incidence of acidosis in patients receiving metformin with and without risk factors for lactic acidosis.

Published in:

Therapeutic Advances in Chronic Disease, 2018, v. 9, n. 9, p. 179, doi. 10.1177/2040622318779760

By:

Trinkley, Katy E.;
Anderson, Heather D.;
Nair, Kavita V.;
Malone, Daniel C.;
Saseen, Joseph J.

Publication type:

Article

Long-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis.

Published in:

Patient Preference & Adherence, 2017, v. 11, p. 1035, doi. 10.2147/PPA.S134865

By:

Foley, John F.;
Nair, Kavita V.;
Vollmer, Timothy;
Stephenson, Judith J.;
Niecko, Timothy;
Agarwal, Sonalee S.;
Watson, Crystal

Publication type:

Article

An evaluation of the impact of patient cost sharing for antihypertensive medications on adherence, medication and health care utilization, and expenditures.

Published in:

Patient Preference & Adherence, 2012, v. 6, p. 63, doi. 10.2147/PPA.S28396

By:

Pesa, Jacqueline A.;
Den Bos, Jill Van;
Gray, Travis;
Hartsig, Colleen;
McQueen, Robert Brett;
Saseen, Joseph J.;
Nair, Kavita V.

Publication type:

Article

The epidemiology and clinical presentation of seropositive neuromyelitis optica spectrum disorder in a US population.

Published in:

Annals of Clinical & Translational Neurology, 2025, v. 12, n. 1, p. 169, doi. 10.1002/acn3.52268

By:

Carlson, Aaron M.;
Sollero, Carlos E.V.;
Wolf, Andrew B.;
Sillau, Stefan;
Schmitt, Barrie L.;
Money, Kelli M.;
Nair, Kavita V.;
Piquet, Amanda L.;
Bennett, Jeffrey L.

Publication type:

Article

Shifting patterns of multiple sclerosis treatment in a highly prevalent United States population.

Published in:

Annals of Clinical & Translational Neurology, 2024, v. 11, n. 6, p. 1526, doi. 10.1002/acn3.52069

By:

Kwon, Sue;
Sillau, Stefan;
Corboy, John R.;
Nair, Kavita V.;
Carlson, Aaron M.

Publication type:

Article

Safety and patient experience with at‐home infusion of ocrelizumab for multiple sclerosis.

Published in:

Annals of Clinical & Translational Neurology, 2023, v. 10, n. 4, p. 579, doi. 10.1002/acn3.51745

By:

Barrera, Britney;
Simpson, Haley;
Engebretson, Eric;
Sillau, Stefan;
Valdez, Brooke;
Parra‐González, José;
Winger, Ryan C.;
Epperson, Lou Anne;
Banks, Ashley;
Pierce, Kathryn;
Spotts, Melanie;
O'Gean, Katie;
Alvarez, Enrique;
Gross, Robert;
Piquet, Amanda L.;
Schreiner, Teri;
Corboy, John R.;
Pei, Jinglan;
Vollmer, Timothy L.;
Nair, Kavita V.

Publication type:

Article

Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment.

Published in:

Annals of Clinical & Translational Neurology, 2019, v. 6, n. 2, p. 252, doi. 10.1002/acn3.700

By:

Vollmer, Brandi L.;
Nair, Kavita V.;
Sillau, Stefan;
Corboy, John R.;
Vollmer, Timothy;
Alvarez, Enrique

Publication type:

Article

Brain Atrophy Rates for Stable Multiple Sclerosis Patients on Long-Term Fingolimod versus Glatiramer Acetate.

Published in:

Frontiers in Neurology, 2020, v. 11, p. N.PAG, doi. 10.3389/fneur.2020.01045

By:

Honce, Justin M.;
Nair, Kavita V.;
Hoyt, Brian D.;
Seale, Rebecca A.;
Sillau, Stefan;
Engebretson, Eric;
Schurr, Brittany;
Corboy, John R.;
Vollmer, Timothy L.;
Alvarez, Enrique

Publication type:

Article

Impact of Treatment by NCQA-Certified Physicians on Diabetes-Related Outcomes.

Published in:

American Health & Drug Benefits, 2011, v. 4, n. 7, p. 429

By:

Pinsky, Brett;
Harnett, James;
Paulose-Ram, Ryne;
Mardekian, Jack;
Samant, Navendu;
Nair, Kavita V.

Publication type:

Article

STAKEHOLDER PERSPECTIVE: Orphan Drugs: The Potential Impact of Generic Biologics.

Published in:

2010

By:

Nair, Kavita V.

Publication type:

Opinion

Role of the Bruton Tyrosine Kinase Pathway in Multiple Sclerosis.

Published in:

American Journal of Managed Care, 2022, p. S323, doi. 10.37765/ajmc.2022.89312

By:

Nair, Kavita V.

Publication type:

Article

Persistent Use of Against-Label Statin-Fibrate Combinations from 2003-2009 Despite United States Food and Drug Administration Dose Restrictions.

Published in:

Pharmacotherapy, 2012, v. 32, n. 7, p. 623, doi. 10.1002/j.1875-9114.2011.01090.x

By:

Alford, Julie C.;
Saseen, Joseph J.;
Allen, Richard R.;
Nair, Kavita V.

Publication type:

Article

Characterizing the Journey of Early Alzheimer's Disease in Patients Initiating Lecanemab Treatment in the United States: A Real-World Evidence Study.

Published in:

Neurology & Therapy, 2025, v. 14, n. 3, p. 1115, doi. 10.1007/s40120-025-00756-4

By:

Sabbagh, Marwan N.;
Zhao, Chenyue;
Mahendran, Malena;
Jang, Se Ryeong;
Laliberté, François;
Toyosaki, Hideki;
Zhang, Kaixin;
Frech, Feride;
Nair, Kavita V.

Publication type:

Article

Comparison of patient characteristics and gout-related health-care resource utilization and costs in patients with frequent versus infrequent gouty arthritis attacks.

Published in:

2012

By:

Saseen, Joseph J.;
Agashivala, Neetu;
Allen, Richard Read;
Ghushchyan, Vahram;
Yadao, Anthony M.;
Nair, Kavita V.

Publication type:

Journal Article

Comparison of patient characteristics and gout-related health-care resource utilization and costs in patients with frequent versus infrequent gouty arthritis attacks.

Published in:

Rheumatology, 2012, v. 51, n. 11, p. 2004, doi. 10.1093/rheumatology/kes183

By:

Saseen, Joseph J.;
Agashivala, Neetu;
Allen, Richard Read;
Ghushchyan, Vahram;
Yadao, Anthony M.;
Nair, Kavita V.

Publication type:

Article